Xeomin® and BOTOX® Cosmetic Parallel Clinical Trial Results
Posted May 21, 2015 in Cellulite Treatment
A new head-to-head, randomized, double-blind, parallel trial has analyzed clinical result variants between Xeomin® and BOTOX® Cosmetic. The trials, conducted on 250 healthy female patients with moderate to severe glabellar lines, found that those injected with Xeomin were more likely to continue seeing results after four months.
If you live in or around Los Angeles and are interested in learning more about Xeomin, BOTOX® Cosmetic, and other nonsurgical facial treatments, please call Dr. Andre Berger at 310.695.1051 to schedule a consultation today.
Botulinum toxin is the active ingredient in both Xeomin and BOTOX® Cosmetic – though the potency units of each treatment are different. While this study suggests results from Xeomin are slightly longer-lasting than BOTOX® Cosmetic, neither option is ideal for every single patient. Dr. Berger offers a full range of nonsurgical facial rejuvenation options to meet the varied needs of each patient he sees. The best way to learn which of these options is right for you is through a one-on-one consultation at our comfortable and convenient Beverly Hills office.
To schedule your initial consultation with Dr. Berger, please contact Rejuvalife® today. Based in Beverly Hills, Dr. Berger welcomes patients from all Los Angeles area communities.